The global veterinary molecular diagnostics market reached a size of USD 745.6 million in 2024 and is forecasted to grow to USD 1,482.2 million by 2033. It is expected to expand at a CAGR of 7.54% during the period 2025–2033. This market growth is driven by the increasing adoption of pets, advancements in molecular diagnostic technologies, and stricter regulatory guidelines in veterinary molecular diagnostics. Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Veterinary Molecular Diagnostics Market Key Takeaways

• Current Market Size: USD 745.6 Million in 2024
• CAGR: 7.54% during 2025-2033
• Forecast Period: 2025-2033
• Increasing pet ownership is significantly propelling market growth.
• Rising demand for rapid and accurate molecular diagnostics helps prevent disease transmission between animals and humans.
• Personalized medicine utilization in veterinary care is enhancing treatment plans and disease prediction.
• North America leads the market due to higher pet adoption rates and diagnostic test affordability.
• Molecular diagnostic advancements like PCR and NGS support early and precise disease management.

Sample Request Link: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market/requestsample

Market Growth Factors

The growing adoption of pets internationally is a pivotal factor fueling the veterinary molecular diagnostics market. For example, over 59% of households in the United Kingdom owned pets in 2021, with 32.6 million pets accounted for. Globally, the dog population was approximately 604.5 million and the cat population around 408.2 million in 2022. Increasing expenditures in the American pet industry, reaching US$ 123.6 billion in 2021, further drive demand for veterinary diagnostic services and technologies.

The rising prevalence of animal diseases is another primary driver. Studies have shown domestic dogs as potential hosts for zoonotic parasites such as Echinococcus multilocularis, posing significant health risks. Additionally, it is estimated that one in five farm animals is lost annually due to diseases. Economic losses from conditions like bovine respiratory diseases exceed US$ 1 billion yearly, and diseases such as pinkeye and foot rot also incur substantial financial impacts. These factors contribute to increased demand for rapid and accurate veterinary molecular diagnostic solutions.

Advancements in molecular diagnostic technologies support market growth by providing sensitive, precise tools like real-time PCR, next-generation sequencing, and microarray analysis. Recent product launches, such as Carolina Liquid Chemistries Corp’s portable analyzer and Micro Vet Diagnostics’ Micro-chem II system, enhance veterinary laboratories’ efficiency and reduce test turnaround times. These technological advancements enable better health management of animals, driving the widespread adoption of molecular diagnostics in veterinary practice.

Market Segmentation

By Product:

• Kits and Reagents: These include molecular diagnostic tools vital for disease detection, genotyping, and genetic research in animals. Kits for next-generation sequencing aid in understanding pathogen genomes and epigenetics.
• Instruments
• Software and Services

By Technology:

• Real Time PCR: A method to amplify and quantify DNA/RNA in real-time, enabling early diagnosis of pathogens in animals.
• Microarray
• DNA Sequencing

By Animal Type:

• Companion Animal: Includes pets like dogs and cats, prone to genetic and infectious diseases; molecular diagnostics assist in disease detection and breeding management.
• Livestock Animal

By Disease Type:

• Vector-borne Diseases: Transmitted by arthropod vectors, significantly affecting livestock productivity; molecular diagnostics provide swift and precise pathogen identification.
• Respiratory Pathogens
• Diarrhea Pathogens
• Others

By End User:

• Veterinary Hospitals: Utilize molecular diagnostics for disease monitoring, treatment, and biosecurity.
• Clinical Laboratories: Provide rapid, precise molecular diagnostic services for animal healthcare.
• Research Institutes: Employ molecular methods to study animal health, genetics, and disease mechanisms.

By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America dominates the veterinary molecular diagnostics market, driven by rising pet ownership and the affordability of molecular diagnostic tests for veterinary practices. In 2024, 66% of U.S. households owned pets. Additionally, the increasing prevalence of animal diseases and related veterinary expenditures bolster market growth. Continuous product launches, such as expansions by IDEXX Laboratories in cancer diagnostics, further strengthen North America's leading position.

Recent Developments & News

• May 2024: Fuse Diagnostics completed an oversubscribed seed round raising £1.6 million (US$ 2 million) for developing its Apex clinical diagnostics and veterinary applications range.
• February 2024: MiDOG Animal Diagnostics LLC rebranded to broaden diagnostic capabilities for various animal species with next-generation DNA sequencing.
• November 2023: Antech, part of Mars Petcare, opened a new UK veterinary diagnostics laboratory in Warwick, expanding its UK lab network.

Key Players

• Antech Diagnostics, Inc.
• bioMérieux
• Bioneer Corporation
• HealthGene Corp.
• IDEXX
• INDICAL BIOSCIENCE GmbH
• Ingenetix GmbH
• Neogen Corporation
• Novacyt Group
• Thermo Fisher Scientific Inc.
• Veterinary Molecular Diagnostics Inc.
• Zoetis Services LLC

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302